Hepatitis A virus protein 2B suppresses beta interferon (IFN) gene transcription by interfering with IFN regulatory factor 3 activation

被引:35
|
作者
Paulmann, Dajana [1 ]
Magulski, Thomas [1 ]
Schwarz, Rebecca [1 ]
Heitmann, Lisa [1 ]
Flehmig, Bertram [2 ]
Vallbracht, Angelika [1 ]
Dotzauer, Andreas [1 ]
机构
[1] Univ Bremen, Dept Virol, D-28359 Bremen, Germany
[2] Univ Tubingen, Childrens Hosp, Dept 1, D-72076 Tubingen, Germany
来源
JOURNAL OF GENERAL VIROLOGY | 2008年 / 89卷
关键词
D O I
10.1099/vir.0.83521-0
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Hepatitis A virus (HAV) antagonizes the innate immune response by inhibition of retinoic acid-inducible gene I-mediated and melanoma differentiation-associated gene 5-mediated beta interferon (IFN-beta) gene expression. This study showed that this is due to an interaction of HAV with mitochondrial antiviral signalling protein (MAVS)-dependent signalling, in which the viral nonstructural protein 2B and the protein intermediate 3ABC recently suggested in this context seem to be involved, cooperatively affecting the activities of MAVS and the kinases TANK-binding kinase 1 (TBK1) and the inhibitor of NF-kappa B kinase epsilon (IKK epsilon). In consequence, interferon regulatory factor 3 (IRF-3) is not activated. As IRF-3 is necessary for IFN-beta transcription, inhibition of this factor results in efficient suppression of IFN-beta synthesis. This ability might be of vital importance for HAV, which is an exceptionally slow growing virus sensitive to IFN-beta, as it allows the virus to establish infection and maintain virus replication for a longer period of time.
引用
收藏
页码:1593 / 1604
页数:12
相关论文
共 50 条
  • [21] Japanese Encephalitis Virus NS5 Inhibits Type I Interferon (IFN) Production by Blocking the Nuclear Translocation of IFN Regulatory Factor 3 and NF-κB
    Ye, Jing
    Chen, Zheng
    Li, Yunchuan
    Zhao, Zikai
    He, Wen
    Zohaib, Ali
    Song, Yunfeng
    Deng, Chenglin
    Zhang, Bo
    Chen, Huanchun
    Cao, Shengbo
    JOURNAL OF VIROLOGY, 2017, 91 (08)
  • [22] POSSIBLE INVOLVEMENT OF THE TRANSCRIPTION FACTOR ISGF3-GAMMA IN VIRUS-INDUCED EXPRESSION OF THE IFN-BETA GENE
    KAWAKAMI, T
    MATSUMOTO, M
    SATO, M
    HARADA, H
    TANIGUCHI, T
    KITAGAWA, M
    FEBS LETTERS, 1995, 358 (03) : 225 - 229
  • [23] Interferon alpha2b (IFN 2b) plus riboflavin (RIBA) for the treatment of chronic hepatitis C in prior interferon (IFN) non-responders (NR): Interim results of a community trial
    Lewis, JH
    Gallagher, JE
    Gibbs, L
    GASTROENTEROLOGY, 1998, 114 (04) : A1288 - A1288
  • [24] Pegylated interferon alpha 2b (PEG-IFN) plus ribavirin (RBV) versus pegylated interferon alpha 2b for chronic hepatitis C in HIV patients
    Cargnel, A
    Angeli, E
    Mainini, A
    Gubertini, G
    Giorgi, R
    Orlando, G
    Duca, P
    GASTROENTEROLOGY, 2003, 124 (04) : A766 - A766
  • [25] NSs Protein of Sandfly Fever Sicilian Phlebovirus Counteracts Interferon (IFN) Induction by Masking the DNA-Binding Domain of IFN Regulatory Factor 3
    Wuerth, Jennifer Deborah
    Habjan, Matthias
    Wulle, Julia
    Superti-Furga, Giulio
    Pichlmair, Andreas
    Weber, Friedemann
    JOURNAL OF VIROLOGY, 2018, 92 (23)
  • [26] Health related quality of life (HRQOL) in patients treated with interferon α-2B (IFN) for chronic hepatitis C (HCV).
    Venkataramani, A
    Rond, R
    Lyche, KD
    GASTROENTEROLOGY, 1998, 114 (04) : A1359 - A1359
  • [27] Novel alpha interferon (IFN-α) variant with improved inhibitory activity against hepatitis C virus genotype 1 replication compared to IFN-α2b therapy in a subgenomic replicon system
    Escuret, Vanessa
    Martin, Amaury
    Durantel, David
    Parent, Romain
    Hantz, Olivier
    Trepo, Christian
    Menguy, Thierry
    Bottius, Emmanuel
    Dardy, Jerome
    Maral, Jean
    Escary, Jean Louis
    Zoulim, Fabien
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (12) : 3984 - 3991
  • [28] Ribavirin/interferon α-2b (IFN) therapy is very effective in the treatment of chronic hepatitis C genotype 2&3 patients who have failed to respond virologically to IFN monotherapy.
    Pimstone, NR
    Canio, JB
    Chiang, MH
    Kokosinski, J
    Powell, JS
    Saicheur, T
    Sheykhzadeh, PI
    Yu, AS
    GASTROENTEROLOGY, 2001, 120 (05) : A382 - A382
  • [29] Regulation of the germinal center gene program by interferon (IFN) regulatory factor 8/IFN consensus sequence-binding protein (vol 203, pg 63, 2006)
    Lee, Chang Hoon
    Melchers, Mark
    Wang, Hongsheng
    Torrey, Ted A.
    Slota, Rebecca
    Qi, Chen-Feng
    Kim, Ji Young
    Lugar, Patricia
    Kong, Hee Jeong
    Farrington, Lila
    van der Zouwen, Boris
    Zhou, Jeff X.
    Lougaris, Vassilios
    Lipsky, Peter E.
    Grammer, Amrie C.
    Morse, Herbert C., III
    JOURNAL OF EXPERIMENTAL MEDICINE, 2008, 205 (06): : 1507 - 1507
  • [30] IFN-stimulated Gene Expression Is a Useful Potential Molecular Marker of Response to Antiviral Treatment with Peg-IFNα 2b and Ribavirin in Patients with Hepatitis C Virus Genotype 1
    Sara Sixtos-Alonso, Maria
    Sanchez-Munoz, Fausto
    Francisco Sanchez-Avila, Juan
    Avalos Martinez, Rosalba
    Dominguez Lopez, Aaron
    Vargas Vorackova, Florencia
    Uribe, Misael
    ARCHIVES OF MEDICAL RESEARCH, 2011, 42 (01) : 28 - 33